publication . Article . 2005

Expression of Major Histocompatibility Complex class II and costimulatory molecules in oral carcinomas in vitro

Villarroel, Mariana; Speight, Paul M.; Barrett, A. William;
Open Access Spanish
  • Published: 01 Jul 2005
  • Publisher: Sociedad Española de Medicina Oral
  • Country: Spain
El descubrimiento de que el epitelio escamoso estratificado que cubre la mucosa oral podia expresar moleculas del Complejo Mayor de Histocompatibilidad clase II en varias condiciones patologicas de tipo inflamatorio abrio la posibilidad de que los queratinocitos orales sean celulas inmunologicamente activas, las cuales pueden funcionar con .celulas presentadoras de antigenos'ñ. Para una efectiva activacion de los linfocitos T, las celulas presentadoras de antigenos requieren, ademas de la expresion de moleculas del Complejo Mayor de Histocompatibilidad clase II, senales co-estimuladoras. El proposito del presente estudio fue determinar la expresion de moleculas ...
free text keywords: CD40, CD80, CD86, Complejo Mayor de Histocompatibilidad, epitelio oral, carcinoma oral, Costimulatory molecules, Major Histocompatibility Complex, oral epithelium, oral squamous cell carcinoma, Odontología, Ciencias de la salud, UNESCO::CIENCIAS MÉDICAS
Related Organizations
48 references, page 1 of 4

1. Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev 2003;192:161-80. [OpenAIRE]

2. Yokochi T, Holly RD, Clark EA. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and BurkittÊs lymphomas. J Immunol 1982;128:823-7.

3. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9.

4. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA, Jr., Lombard LA et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-11. [OpenAIRE]

5. Henry J, Miller MM, Pontarotti P. Structure and evolution of the extended B7 family. Immunol Today 1999;20:285-8.

6. Symington FW, Brady W, Linsley PS. Expression and function of B7 on human epidermal Langerhans cells. J Immunol 1993;150:1286-95.

7. Valle A, Aubry JP, Durand I, Banchereau J. IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions. Int Immunol 1991;3:229-35.

8. Chambers CA. The expanding world of co-stimulation: the two-signal model revisited. Trends Immunol 2001;22:217-23.

9. Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol 1997;158:2713-22.

10. Najafian N, Khoury SJ. T cell costimulatory pathways: blockade for autoimmunity. Expert Opin Biol Ther 2003;3:227-36.

11. Vogel LA, Noelle RJ. CD40 and its crucial role as a member of the TNFR family. Semin Immunol 1998;10:435-42.

12. Gaspari AA, Sempowski GD, Chess P, Gish J, Phipps RP. Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur J Immunol 1996;26:1371-7.

13. Li J, Yang Y, Inoue H, Mori M, Akiyoshi T. The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: its regulation by interferon gamma and interleukin-10. Cancer Immunol Immunother 1996; 43:213-9.

14. Tatsumi T, Takehara T, Katayama K, Mochizuki K, Yamamoto M, Kanto T et al. Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma. Hepatology 1997;25:1108-14.

15. Lang S, Whiteside TL, Lebeau A, Zeidler R, Mack B, Wollenberg B. Impairment of T-cell activation in head and neck cancer in situ and in vitro: strategies for an immune restoration. Arch Otolaryngol Head Neck Surg 1999;125:82-8. [OpenAIRE]

48 references, page 1 of 4
Any information missing or wrong?Report an Issue